HMGCR and rotator cuff syndrome: Our research, which involves constructing various genetic variables, demonstrates a correlation between HMGCR inhibitors and a reduced risk of rotator cuff syndrome, thereby highlighting HMGCR as a promising therapeutic target for prevention.